| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
person
GenCanna
|
Financial |
5
|
1 |
This document is page 61 of a 'Cowen Collaborative Insights' report dated February 25, 2019, analyzing private companies in the CBD/hemp industry (Botanica, GenCanna, Highline Wellness, Lazarus Naturals, Lord Jones, and Mary's). While stamped 'HOUSE_OVERSIGHT_024877', indicating it is part of a larger document production (likely related to financial oversight), the page content itself is purely market research and contains no direct references to Jeffrey Epstein or his associates. The sidebar indicates the report was intended for Michael Cella at Cowen.
This document is Page 125 of a financial report produced by Ackrell Capital, LLC, titled 'Chapter VII Capital Markets for Cannabis Companies.' It contains a data table listing 'Over The Counter' cannabis stocks with market values greater than $25 million as of November 30, 2017. The table provides financial metrics such as stock price, market value, enterprise value, and revenue for numerous entities. The document bears the Bates stamp 'HOUSE_OVERSIGHT_024761', indicating it was part of a document production to the House Oversight Committee, likely related to investigations into financial records.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity